Evidence map›Paper›PMID 38600543›Full record

Observational studyArthritis research & therapy2024

Anxiety and depression symptoms in adolescents and young adults with juvenile idiopathic arthritis: results of an outpatient screening.

Florian Milatz, Jens Klotsche, Martina Niewerth, Claudia Sengler, Daniel Windschall, Tilmann Kallinich, Frank Dressler, Ralf Trauzeddel, Reinhard W Holl, Ivan Foeldvari and 14 more

Open access · goldAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Arthritis research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. [Artificial intelligence in preventive medicine for children and adolescents-applications and acceptance].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2025
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 17 institutions in 2 countries.

Florian MilatzProgramme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Charitéplatz 1, 10117, Berlin, Germany. florian.milatz@drfz.de.
Jens KlotscheProgramme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Charitéplatz 1, 10117, Berlin, Germany.
Martina NiewerthProgramme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Charitéplatz 1, 10117, Berlin, Germany.
Claudia SenglerProgramme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Charitéplatz 1, 10117, Berlin, Germany.
Daniel WindschallClinic of Paediatric and Adolescent Rheumatology, Northwest German Centre for Rheumatology, St. Josef- Stift Sendenhorst, Sendenhorst, Germany.
Tilmann KallinichDepartment of Paediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt - Universität zu Berlin, Berlin, Germany.
Frank DresslerDepartment of Paediatric Pneumology, Allergology and Neonatology, Children's Hospital, Hannover Medical School, Hannover, Germany.
Ralf TrauzeddelDepartment of Paediatrics, Paediatric and Adolescent Rheumatology, Helios Klinik Berlin-Buch, Berlin, Germany.
Reinhard W HollInstitute for Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany.
Ivan FoeldvariHamburg Centre for Paediatric and Adolescent Rheumatology, Schön Klinik Hamburg Eilbek, Hamburg, Germany.
Normi BrückDepartment of Paediatrics, Carl Gustav Carus, University Hospital, Technical University Dresden, Dresden, Germany.
Svenja TemmingDepartment of Paediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt - Universität zu Berlin, Berlin, Germany.
Toni HospachDepartment of Paediatrics, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.
Petra WarschburgerDepartment of Psychology, University of Potsdam, Potsdam, Germany.
Rainer BerendesPediatric Rheumatology, Children's Hospital St. Marien, Landshut, Germany.
Gabriele ErbisDivision of Pediatric Rheumatology and autoinflammation reference centre Tuebingen (arcT), Department of Pediatrics, University Hospital Tuebingen, member of ERN-RITA, Tuebingen, Germany.
Jasmin B Kuemmerle-DeschnerDivision of Pediatric Rheumatology and autoinflammation reference centre Tuebingen (arcT), Department of Pediatrics, University Hospital Tuebingen, member of ERN-RITA, Tuebingen, Germany.
Frank Weller-HeinemannDepartment of Pediatrics and Adolescent Medicine, Pediatric Rheumatology, Eltern-Kind-Zentrum Prof. Hess, Klinikum Bremen-Mitte, Bremen, Germany.
Johannes-Peter HaasGerman Centre for Paediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, Germany.
Annabel S Müller-StierlinDepartment of Psychiatry and Psychotherapy II, Ulm University, Ulm, Germany.
Agnes MutterDepartment of Clinical Psychology and Psychotherapy, Institute of Psychology and Education, Faculty of Engineering, Computer Science and Psychology, Ulm University, Ulm, Germany.
Thomas MeissnerDepartment of General Paediatrics, Neonatology and Paediatric Cardiology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
Harald BaumeisterDepartment of Clinical Psychology and Psychotherapy, Institute of Psychology and Education, Faculty of Engineering, Computer Science and Psychology, Ulm University, Ulm, Germany.
Kirsten MindenProgramme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Charitéplatz 1, 10117, Berlin, Germany.
German Rheumatism Research Centre · DEUniversität Ulm · DEHeinrich Heine University Düsseldorf · DECharité - Universitätsmedizin Berlin · DEFreie Universität Berlin · DEGerman Center for Pediatric and Adolescent Rheumatology · DEHelios Hospital Berlin-Buch · DEHumboldt-Universität zu Berlin · DEKlinikum Bremen-Mitte · DEKlinikum Stuttgart · DELeibniz Association · DEMartin Luther University Halle-Wittenberg · DEMedizinische Hochschule Hannover · DESchön Klinik Hamburg Eilbek · DESt. Marien Hospital · DEUniversity Hospital Carl Gustav Carus · DEUniversity of Potsdam · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies have shown that growing up with rheumatic conditions can fuel dissatisfaction and psychological distress, which in turn affects disease self-management and treatment adherence. Primary objective of this study was to estimate the prevalence of anxiety and depression symptoms in adolescents and young adults (AYA) with juvenile idiopathic arthritis (JIA) and to identify correlates of conspicuous screening results.

methodsInitiated as part of the COACH multicenter observational study, outpatients aged 12 to 21 years participating in the National Pediatric Rheumatological Database (NPRD) were prospectively screened for mental health using the Patient Health Questionnaire-9 (PHQ-9) and the Generalised Anxiety Disorder Scale-7 (GAD-7).

resultsData from 1,150 adolescents with JIA (mean age 15.6 ± 2.2 years; mean disease duration 7.2 ± 4.9 years, 69% female, 43% oligoarthritis, 26% polyarthritis) were analysed. Overall, 32.7% (n = 316) of AYA showed conspicuous screening results, of whom 30.4% reported clinically relevant suicidal or self-harm thoughts. About 19% of screened patients showed moderate to severe depressive or anxious symptoms. AYA with conspicuous screening results were older (15.8 vs. 15.2 years; p < 0.0001), more often female (81% vs. 64%; p < 0.0001) and more often overweight (25% vs. 17%; p = 0.006). They had higher disease activity (physician global assessment on NRS 0-10; 1.7 vs. 1.2; p < 0.0001), more functional limitations (CHAQ; 0.44 vs. 0.14; <0.0001) and rated their health status worse (NRS 0-10; 3.5 vs. 1.8; p < 0.0001) than AYA with inconspicuous screening results. Females (OR 2.33 [CI 1.53-3.56]; p < 0.0001), older age (OR 1.09 [CI 1.01-1.18]; p = 0.026), patients with more functional limitations (OR 3.36 [CI 1.98-5.72]; p < 0.0001), and patients with worse subjective health status (OR 1.17 [CI 1.07-1.27]; p < 0.0001) were more likely to have a conspicuous screening result. Regular sports participation was associated with a lower likelihood of conspicuous screening result (OR 0.69 [CI 0.49-0.98]; p = 0.039).

conclusionsA large-scale outpatient screening of AYA with JIA in Germany shows a high prevalence of anxiety and depression symptoms. The need for routine screening for early detection of mental health problems became apparent.

Indexed as

Arthritis, JuvenileOutpatientsAdolescentAnxietyChildDepressionFemaleHumansMaleMental HealthYoung AdultAdolescentsAnxietyDepressionInternalizing symptomsJuvenile idiopathic arthritisMental healthScreening

Identifiers

PMID38600543
PMCPMC11005270
OpenAlexW4394688821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.